High-resolution transcription mapping localized a spliced 2.7-kilobase herpes simplex virus type 1 mRNA. The 4-kilobase intron of this transcript encodes a nested set of transcripts on the opposite DNA strand. The nucleotide sequence of the DNA encoding the left-hand and right-hand exons of the spliced transcript was determined, and the salient features are presented here. Of major interest is that both exons contained regions within several hundred bases of the splice donor and acceptor sites which showed homology to two regions of the Epstein-Barr virus genome, which are themselves 3 kilobases apart. The spliced herpes simplex virus transcript encoded a translational reading frame which could encode a protein with an approximate size of 75,000 daltons. This value is in agreement with in vitro translation data. The predicted amino acid sequence of the herpes simplex virus protein had significant homology with putative amino acid sequences encoded by the homologous Epstein-Barr virus DNA sequences. (1, 2, (10) (11) (12) (13) (14) 16) . RNA was isolated at 6 h postinfection. RNA was size-fractionated by electrophoresis on 1.4% agarose gels containing 10 mM methylmercury hydroxide (4) as previously described (1, 2, 14, 16).
As recentlv reviewed (24; E. Wagner, in B. Roizman, ed., Herpesviruses, vol. 3, in press), correlation between the genetic maps and transcription maps for herpes simplex virus type 1 (HSV-1) is generally excellent. Detailed transcription maps for the virus indicate that the vast majority of transcripts are unspliced and have promoter-control regions immediately 5' to the mRNA cap sites. Nested sets of transcripts can be identified. These are partially overlapping transcripts which can share polyadenylation sites yet encode unique polypeptides. Other partially overlapping clusters have been identified which have a common 5' cap site but which differ in the polyadenylation site. Such a situation leads to mRNAs which are "redundant" in that they each encode the same protein. Variations on these patterns are common.
Splicing of mRNA is not common in HSV-1 mRNA metabolism. The reason for this is unclear, since other herpesviruses encode spliced mRNAs. Furthermore, some spliced mRNAs are expressed during HSV infection. In HSV-1 infection, most splices are short. It was therefore surprising to note the occurrence of a late HSV-1 spliced mRNA which is encoded by a DNA sequence containing a 4-kilobase (kb) intron. This transcript is located in a region (0.185 to 0.225 map units [m.u.]) with no reported genetic markers (25; P. Schaffer, personal communication). As described in this communication, analysis of the DNA sequence encoding the transcript showed that it had significant homology with an analogous region encoded by Epstein-Barr virus (EBV) DNA, the sequence of which has been reported by Baer et al. (3) Such homology is compelling evidence that this unusual (for HSV) spliced transcript encodes a function important for the replication of herpesviruses in general.
MATERIALS AND METHODS Cells and virus. For RNA preparation, plaque-purified isolates of the KOS strain of HSV-1 were used to infect * Corresponding author.
HeLa cells. Monolayer cultures of HeLa cells were grown at 37°C in Eagle minimal essential medium containing 10% calf serum, penicillin, and streptomycin.
Enzymes. All restriction enzymes and bacterial alkaline phosphatase were obtained from Bethesda Research Laboratories. Digestions were carried out in buffers recommended by the supplier. Bacteriophage T4 polynucleotide kinase (Bethesda Research Laboratories) was used for 5' end labeling as described by Maxam and Gilbert (20) . Escherichia coli DNA polymerase I (Klenow fragment; Boehringer-Mannheim Biochemicals) was used to generate 3'-end-labeled DNA by the method of Maniatis et al. (19) .
Isolation, labeling, and size fractionation of polyribosomal RNA. Monolayer cultures of HeLa cells (2 x 107 cells per flask) were infected for 30 min at a multiplicity of 10 PFU of virus per cell in phosphate-buffered saline containing 0.1% glucose and 1.0% fetal calf serum. Polyribosomes were isolated from the cytoplasm of HSV-1-infected cells by the magnesium precipitation method of Palmiter (22) . Polyadenylic acid-containing [poly(A)] mRNA was isolated from total rRNA by oligodeoxythymidylic acid-cellulose (Collaborative Research, Inc.) chromatography. This is referred to as HSV poly(A) mRNA. Details of this procedure have been presented elsewhere (1, 2, (10) (11) (12) (13) (14) 16) . RNA was isolated at 6 h postinfection. RNA was size-fractionated by electrophoresis on 1.4% agarose gels containing 10 mM methylmercury hydroxide (4) as previously described (1, 2, 14, 16) .
Recombinant DNA. All recombinant DNA clones described in this paper were derived from either BamHI-HindIII . Procedures for cloning HSV-1 DNA fragments in the pBR322 vector have been described previously (1, 7) . Cloned DNA fragments were named as described previously and located by their map coordinates on the prototype arrangement of the HSV-1 genome (7).
In situ Northern RNA blots. Unless noted otherwise, 10-,ug samples of HSV poly(A) mRNA were fractionated on methylmercury gels and dried onto Whatman 3 MM paper under vacuum as previously described (10, 14, 16 (3, 000 Ci/mmol; Amersham Corp.).
Isolation of restriction fragment-specific mRNA. Restriction fragment-specific mRNA was isolated from HSV poly(A) mRNA by preparative hybridization to the appropriate DNA covalently coupled to cellulose. Details of coupling DNA to cellulose and preparative hybridization have been described previously (2, 7). Nucleotide sequencing. As described previously (10, 14) , nucleotide sequence analysis was carried out by the method of Maxam and Gilbert (20) .
Nuclease mapping of HSV-1 mRNA. S1 nuclease and exonuclease VII analysis of RNA was carried out essentially as described by Berk and Sharp (5) and as described previously (1, 6-8, 10-14, 16) . Appropriate HSV-1 DNA clones (10 ,ug) were cleaved at the desired site with the appropriate restriction enzyme. The DNA then was 5' end labeled with [_y-32P]ATP (3,000 Ci/mmol; ICN) with polynucleotide kinase (Bethesda Research Laboratories) to a specific activity of 100,000 cpm/,ug of DNA. Alternatively, the DNA was 3' end labeled to the same specific activity by using DNA polymerase I (Klenow fragment) (BoehringerMannheim).
The DNA fragments were then denatured and strand separated on 5% acrylamide gels as described by Maxam and Gilbert (20) . The strand-separated DNA (from 10 pg of cloned DNA) was hybridized with 10 jig of infected-cell mRNA in 0.1 M Na+-0.1 M Herpes (pH 8.0)-0.01 M EDTA at 65°C for 6 to 16 h in a 30-,ul volume. Hybrids were subjected to S1 nuclease (Boehringer-Mannheim) or exonuclease VII (Bethesda Research Laboratories) digestion as described previously (10, 14) . Material was fractionated on a denaturing 5% acrylamide gel, with 5'-end-labeled Hinfl-digested pBR322 DNA fragments used as size standards.
Alternatively, Si-protected products were fractionated on a 1.5% alkaline agarose gel, with 5'-end-labeled HindIII-digested lambda DNA fragments used as size standards (14, 16) .
In vitro translation. Translation of size-fractionated viral mRNA was carried out in vitro with a micrococcal nucleasetreated rabbit reticulocyte system (New England Nuclear Corp.), with [35S]methionine (>800 Ci/mmol) as the radioactive amino acid. Details of the procedure and fractionation of polypeptides in SDS-acrylamide gels by the method of Laemmli (18) have been described in several previous papers (8, 10, 14, 16) . Gels were treated with En3Hance (New England Nuclear Corp.) and dried under vacuum at 60°C, and radioactive bands were localized by autoradiography with Kodak XRP film. Exposure was for 3 to 5 days at -700C.
RESULTS
Location of transcripts between 0.15 and 0.27 m.u. The map (Fig. 1) illustrates pertinent restriction endonuclease sites and the location of HSV-1 transcripts in the 18-kilobasepair region between 0.151 and 0.272 m.u. Characterization of the transcripts between 0.16 and 0.185 m.u. and between 0.225 and 0.27 m.u. is also shown (6, 8) . The preliminary characterization of the transcripts between 0.185 and 0.225 m.u. is the subject of this paper. Temporal classification of individual transcripts was based on the measured abundance of transcripts in the presence and absence of HSV-1 DNA synthesis inhibitors as described previously (17) . These data are not shown here.
Individual cloned HSV-1 DNA fragments which subdivided the region of interest were used as probes for in situ RNA hybridization (Fig. 2) . The sizes of transcripts were calculated from nucleotide sequence data (see below; Draper and Wagner, unpublished data). These do not include the length of poly(A) tails (ca. 200 bases [23] 3.8kb/3,80,000d
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1. Nuclease mapping of the transcripts. The termini of the 2.7-, 1.5-, and 3.65-3.8-kb transcripts were precisely located by Si nuclease and exonuclease VII mapping with hybrids between infected-cell polyribosomal poly(A) RNA (viral mRNA) and strand-separated 5'-or 3'-end-labeled DNA restriction fragments as described in detail previously (8, 14) . Evidence that the 2.7-kb mRNA transcript contains an (Fig. 3B) . Exonuclease VII digestion yielded two other bands, 1,200 and 800 bases in size, which are probably artifacts since they were also observed in exonuclease VII digestion experiments with uninfected HeLa cell RNA (data not shown). The 5' contiguous end of the 2.7-kb mRNA (spliced donor portion) extended only about 700 bases to the 3' side of the EcoRI site at 0.190 m.u. (Fig. 3C) , where mRNA hybridized to EcoRI-XhoI fragment G-U DNA (0.190 to 0.207 m.u.) 3' end labeled at the EcoRI site.
The right-hand portion of the 2.7-kb mRNA was located in a similar manner. S1 nuclease digestion of hybrids between viral mRNA and SalI-XhoI fragment U-V DNA (0.219 to 0.226 m.u.) 5 ' end labeled at the XhoI site yielded fully protected DNA (950 bases long) and minor amounts of DNA fragments 800 and 420 bases long (Fig. 3D ). This result suggested that a major splice acceptor is located near the SalI site at 0.219 m.u. and that other minor sites may be utilized. However, these minor bands were not seen when DNA 5' end labeled at the BamHI site at 0.223 m.u. was used in such experiments. The major acceptor was located 500 bases to the left (5') of the BamHI site at 0.223 m.u. by S1 nuclease digestion of hybrids between viral mRNA and XhoI-BamHI fragment V-A DNA (0.207 to 0.223 m.u.) 5' end labeled at the BamHI site (Fig. 3E) . The 3' end of the 2.7-kb mRNA was located 200 bases to the right (3') of the XhoI site at 0.226 m.u. by carrying out Si nuclease digestion of hybrids between viral mRNA and XhoI-BglII fragment L-P DNA (0.226 to 0.233 m.u.) 3 ' end labeled at the XhoI site (Fig. 3F) .
The nested 1.5-kb and 3.65-3.8-kb mRNAs were transcribed from the opposite DNA strand. These RNAs were precisely mapped in a manner similar to that shown in Fig. 4 (Fig. 4B , tracks S and X). A smaller fragment (ca. 250 bases) seen in the exonuclease VII-digested material was probably an artifact of digestion since it was also seen in a control track of exonuclease VII-digested hybrids between this DNA and uninfected cell mRNA (Fig. 4B, track XC) .
The 5' ends of the 3. Fig. 5 .
The precise 5' end of the 2.7-kb mRNA was localized by using denaturing acrylamide gels to fractionate S1 nuclease digests of hybrids between viral mRNA and an appropriate 5'-end-labeled 380-base AvaI restriction fragment found in HindIII-EcoRI fragment J-D DNA (0.182 to 0.190 m.u.). This fragment was electrophoresed next to a sequence ladder of DNA labeled at the same site (Fig. 6A) . The 5' end of the 3.9-kb mRNA encoding the putative 50,000-Da capsid protein characterized previously (8) is also shown. These data indicate that cap site for these two transcripts, encoded from opposite DNA strands, lie within 100 bases of each other. Note that the sequence ladder is of the DNA strand complementary to the mRNA sequence. The data are summarized in Fig. 5A . There are reasonable TATA and CAT box homologies within 100 bases of the cap sites for both mRNAs, as is normally found for HSV-1 transcripts (24; Wagner, in press).
The putative splice donor was located ca. 700 bases to the right (3') of the EcoRI site at 0.190 m.u. (Fig. 3C) restriction fragment whose right-hand (3') end corresponded to the SmaI site at nucleotides 102 through 107 (Fig. SB) . This potential splice donor sequence (Fig. 5B) shares nominal sequence similarity with other eucaryotic splice donor sequences (21) .
A potential polyadenylation signal, AATAAAAA, was observed 80 bases to the right of the Sail site at 0.195 m.u. (Fig. SB) . The location of this site agrees well with the 3' end of the 1.5-and 3.65-3.8-kb mRNA nested group (Fig. 4A) . This location was confirmed by Si nuclease analysis of hybrids between viral mRNA and a 110-base Sall-SmaI restriction fragment extending to the right of the Sall site at 0.195 m.u. and 3' end labeled at the SmaI site after cleavage with XmaI to generate a 5' overhang (data not shown).
The cap site for the 1.5-kb member of the cluster of mRNAs encoded by the strand opposite the 2.7-kb spliced mRNA intron was located 450 bases to the right (5') of the SalI site at 0.203 m.u. (Fig. 4B) . The nucleotide sequence of DNA in this region is shown in Fig. 5C . Tentative location of the cap site is ca. 25 to 30 bases to the left (3') of the nominal TATA box homology (bases 31 through 39, Fig. 5C ). We suggest that this region is a normal late HSV-1 promoter region on the basis of comparative sequence analysis of HSV-1 promoters (reviewed in Wagner, in press).
One splice acceptor for the 2.7-kb mRNA was precisely located 34 bases to the left (5') of the Sall site at 0.219 m.u. by Si nuclease analysis of hybrids between viral mRNA and XhoI-SaIl fragment V-X DNA (0.210 to 0.219 m.u.) 5' end labeled at the Sall site. An example of fractionated Si nuclease-resistant material compared with a sequence ladder proceeding from the Sall site at 0.219 m.u. is shown in Fig.  6B . The contiguous 5' end of the RNA lies within bases 130 through 136 (Fig. SD) , whose complement is shown in the ladder (Fig. 6B) . The position of this acceptor is 960 bases to the left (5') of the XhoI site at 0.226 m.u., a result in excellent agreement with the data shown in Fig. 3D .
Other potential splice acceptors were suggested from the data (Fig. 3D) . As discussed above, these correspond to regions ca. 150 and 530 bases to the right (3') of the major acceptor indicated here. There are potential sites at nucleo- (Fig. 5D ). Both sites would change the translational reading frame from that generated from the major acceptor. Another potential acceptor is located at nucleotide 22 (Fig. 5D ) to the left (5') of the major acceptor. This site does yield the same translational reading frame as the major acceptor. Its significance will become apparent in the next section, where homology between this HSV-1 DNA sequence and that of EBV DNA is discussed. Finally, several potential splice acceptor sequences are seen in the region around the BamHI site at 0.223 m.u. (not shown). These could function to generate the putative splice acceptor which was observed 420 bases 5' of the XhoI site at 0.226 m.u. (Fig. 3D) .
The cap site of the 3.8-kb mRNA was determined on gels by using sequence ladders as size standards for the Si nuclease-resistant material generated by the Si nuclease digestion of hybrids between viral mRNA and SaIl-BamHI fragment U-A DNA (0.219 to 0.223 m.u.) 5' end labeled at the SalI site (Fig. 6C) . The sequence around this cap site is shown in Fig. SD . A TATA box homology 25 Homology between the 2.7-kb spliced HSV-1 mRNA sequence and sequences of EBV DNA. Because spliced mRNAs are so unusual in HSV-1 transcripts, it seemed possible that the 2.7-kb mRNA might be conserved among other herpesviruses. Therefore, the sequence of HSV-1 DNA encoding the spliced 2.7-kb mRNA was compared with the complete EBV DNA sequence (3 (Science, in press). Significant nucleic acid homology was found to exist between the HSV-1 DNA sequence and two regions of the DNA of EBV B95-8. These regions are separated by ca. 3,000 bases in the EBV genome (Fig. 7) .
The 783 bases of sequence to the left (5') of the HSV-1 splice donor site near the Sall site at 0.195 m.u. was found to be homologous to EBV DNA between bases 125,118 and 125,901. An optimized match between 375 of 780 bases was found, compared with a "random" expected value of less than 190 matches for nonhomologous EBV DNA. The sequence of EBV DNA is numbered as described previously (3) . The region of greatest homology (Fig. 7A ) lay within 300 bases of the splice donor sequence of HSV-1 (182 matches). Homology was lost 3' of the splice donor site in the HSV-1 sequence (nucleotide 1287, Fig. 7A Fig. SE ). This translational reading frame predicts proteins of 70,750 (646 amino acids) or 74,822 (683 amino acids) Da or both, depending on the splice acceptor used. The codon use frequency of the proteins was similar to that seen for other HSV-1 proteins predicted from nucleotide sequence data (reviewed in Wagner, in press). Furthermore, the predicted molecular weight of the protein encoded by the spliced 2.7-kb mRNA was in good agreement with that predicted by the in vitro translation data.
The EBV DNA sequence predicted a protein initiated at base 124,938 (AACATGC) and continuing through the potential splice donors noted in Fig. 7A . A protein translational reading frame is also seen in the EBV sequence corresponding to the major splice acceptor homology shown in Fig. 7B (EBV DNA base 129,114). There is, however, a translation terminator in the EBV DNA sequence to the left (5') of this splice acceptor site and to the right of the site homologous to the putative alternate HSV-1 acceptor site 111 bases to the left (5') of the major one (EBV base 129,186, Fig. 7B ). The translation reading frame for the EBV DNA sequence terminates at base 130,351. A residue molecular weight of ca. 82,000 is predicted for the protein encoded by the combined translation frames if the chain terminator noted above is ignored. If the major splice acceptor is used, then the predicted protein would be ca. 79,000 Da.
The search algorithm of Lipman and Pearson (in press) was used to examine homology between the predicted HSV-1 protein encoded by the spliced 2.7-kb mRNA and the putative protein encoded by EBV (Fig. 8) . Regions of striking homology were seen in the predicted amino acid sequence of the proteins both on the N-terminal side of the predicted splice donor site (52 of 146 amino acids matched; Fig. 8A ) and on the C-terminal side of the two splice acceptor sites (135 of 287 amino acids matched; Fig. 8B ). In this latter case, it is seen that homology extends to the left of the terminator signal in the EBV sequence (X, corresponding to amino acid 62 of EBV, Fig. 8B ). The predicted amino acid homology for the proteins encoded between the potential alternate splice acceptor sites of HSV-1 suggests that there may be alternate splicing patterns in the EBV transcript encoding the protein homologous to that of HSV-1. At any rate, the very striking amino acid sequence homology is compelling evidence for the conservation of this protein between these two rather distantly related herpesviruses.
DISCUSSION
Detailed location of the transcripts described in this report revealed their general similarity to HSV-1 transcripts mapped in other regions. Thus, sequences recognizable as promoter-regulatory regions exist just 5 (15) . Although it cannot yet be said what the functions are of the HSV genes encoding the spliced mRNA and its intron, it is clear that the combination of precise transcript mapping and nucleotide sequence analysis has revealed a potentially interesting herpesvirus genetic marker. The predicted amino acid sequence homology with a putative EBV protein is striking. Furthermore, sequence data will allow the synthesis of specific synthetic polypeptides to be used as immunogens for generating antibodies which can be used to examine the properties and potential function of this protein.
Finally, it is interesting that the arrangement of the transcripts, vis-a-vis the nested set of transcripts encoded from the opposite DNA strand of the spliced 2.7-kb mRNA intron, may also be generally conserved in the EBV genome. Analysis of potential translational reading frames of the EBV DNA indicates several long open frames in the region between bases 126,000 and 129,000 (3). These translation frames are on the opposite coding strand from the EBV frames homologous to those of HSV-1 and could be expressed as a nested set of transcripts analogous to those seen in HSV-1. Further sequence analysis may reveal homologies within such translational reading frames.
